BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15185971)

  • 1. Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria.
    Shimizu S; Suzuki M; Tomoda A; Arai S; Taguchi H; Hanawa T; Kamiya S
    Tohoku J Exp Med; 2004 May; 203(1):47-52. PubMed ID: 15185971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.
    Collins CH; Uttley AH
    J Antimicrob Chemother; 1988 Dec; 22(6):857-61. PubMed ID: 3243734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of novel phenoxazine compounds, 2-amino-4, 4a-dihydro-4alpha, 7-dimethyl-3H-phenoxazine-3-one and 3-amino-1, 4alpha-dihydro-4alpha, 8-dimethyl-2H-phenoxazine-2-one on proliferation of phytohemagglutinin- or anti-human IgM-activated human peripheral blood mononuclear cells.
    Akazawa M; Koshibu-Koizumi J; Iwamoto T; Takasaki M; Nakamura M; Tomoda A
    Tohoku J Exp Med; 2002 Mar; 196(3):185-92. PubMed ID: 12002275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of proliferation of poliovirus and porcine parvovirus by novel phenoxazines, 2-amino-4,4 alpha-dihydro-4 alpha-7-dimethyl-3H-phenoxazine-3-one and 3-amino-1,4 alpha-dihydro-4 alpha-8-dimethyl-2H-phenoxazine-2-one.
    Iwata A; Yamaguchi T; Sato K; Yoshitake N; Tomoda A
    Biol Pharm Bull; 2005 May; 28(5):905-7. PubMed ID: 15863903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of Phx-3 against Helicobacter pylori.
    Hanawa T; Osaki T; Manzoku T; Fukuda M; Kawakami H; Tomoda A; Kamiya S
    Biol Pharm Bull; 2010; 33(2):188-91. PubMed ID: 20118538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
    Kato S; Shirato K; Imaizumi K; Toyota H; Mizuguchi J; Odawara M; Che XF; Akiyama S; Abe A; Tomoda A
    Oncol Rep; 2006 Apr; 15(4):843-8. PubMed ID: 16525669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells.
    Miyano-Kurosaki N; Ikegami K; Kurosaki K; Endo T; Aoyagi H; Hanami M; Yasumoto J; Tomoda A
    J Pharmacol Sci; 2009 May; 110(1):87-97. PubMed ID: 19403995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Aminophenoxazine-3-one and 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells.
    Che XF; Zheng CL; Akiyama S; Tomoda A
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(4):199-213. PubMed ID: 21558757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenoxazine derivatives 2-amino-4,4alpha-dihydro-4alpha-phenoxazine-3-one and 2-aminophenoxazine-3-one-induced apoptosis through a caspase-independent mechanism in human neuroblastoma cell line NB-1 cells.
    Shirato K; Imaizumi K; Abe A; Tomoda A
    Biol Pharm Bull; 2007 Feb; 30(2):331-6. PubMed ID: 17268075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of phenoxazines produced by bovine erythrocytes on colon cancer cells.
    Nakachi T; Tabuchi T; Takasaki A; Arai S; Miyazawa K; Tomoda A
    Oncol Rep; 2010 Jun; 23(6):1517-22. PubMed ID: 20428804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
    Haas H; Michel J; Sacks TG
    Chemotherapy; 1982; 28(1):1-5. PubMed ID: 7056128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.
    Waisser K; Gregor J; Kubicová L; Klimesová V; Kunes J; Machácek M; Kaustová J
    Eur J Med Chem; 2000; 35(7-8):733-41. PubMed ID: 10960190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation and apoptosis in human malignant melanoma G-361 cells induced by 2-aminophenoxazine-3-one.
    Shimizu S; Suzuki M; Miyazawa K; Yokoyama T; Ohyashiki K; Miyazaki K; Abe A; Tomoda A
    Oncol Rep; 2005 Jul; 14(1):41-6. PubMed ID: 15944765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.
    Ho YI; Chan CY; Cheng AF
    J Antimicrob Chemother; 1997 Jul; 40(1):27-32. PubMed ID: 9249201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectively induced apoptosis in human neutrophils in the presence of oxidative phenoxazines, 2-amino-4,4α-dihydryo-4α-7H-phenoxazine-3-one and 2-aminophenoxazine-3-one, preceded by decrease of intracellular pH, depolarization of the mitochondria, and inhibition of superoxide generation.
    Tabuchi T; Che XF; Hiraishi K; Adachi M; Miyano K; Sumimoto H; Tabuchi T; Miyazawa K; Tomoda A
    J Pharmacol Sci; 2011; 117(3):139-48. PubMed ID: 22027095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of 2-amino-4,4alpha-dihydro-4alpha-7-dimethyl-3H-phenoxazine-3-one on poliovirus.
    Iwata A; Yamaguchi T; Sato K; Izumi R; Tomoda A
    Tohoku J Exp Med; 2003 Jul; 200(3):161-5. PubMed ID: 14521260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
    Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
    J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.